2. Type 1 Diabetes Insulin dependent and most severe, pancreas no longer produces insulin. Type 2 Diabetes Diet regulated and pill form pharmaceuticals. Gestational Diabetes Pregnancy based diabetes primarily high risk at 24 weeks of pregnancy.

3. The body is not recognizing body produced insulin, the pancreas increases production to compensate (type 2 diabetes). The insulin produced by the pancreas is no longer recognized by the body (Type 1 diabetes). Due to the insulin production problems with the pancreas, the kidneys have to work harder to produce hormones for the pancreas insulin production. Ultimately affecting the kidneys.

4. Urinating often Feeling very thirsty Feeling very hungry even though you are eating Extreme fatigue Blurry vision Cuts and bruises are slow to heal Numbness/tingling to hands or feet Gestational diabetes does not have same signs and symptoms.

5. Liver problems Kidney failure Pancreatic issues Neuropathy (loss of feeling to limbs) Limb amputations Vision problems

6. Americans 25 or older who die approximately 17 percent have diabetes (Engelgau et al, 2004). Indicated by Center for Disease and Prevention fact sheet 2011, diabetes was a contributing factor in 71,382 deaths in 2007. Projected prevalence from 14% in 2010 to 21% of US population will have diabetes by 2050 (Boyle et al, 2010).

7. Source: SEARCH for Diabetes in Youth Study RATE per 100,000 per year

8. According to the 2007 death registry in Mexico type 2 diabetes is the second leading cause of death. It is estimated that the diabetic population will increase a conservatively 2.1% between 2010-1030 (Shaw et al 2010). The principal cause of death in Mexican women is diabetes (Rull et al 2005).

9. Gender Ethnicity (According to Lopez and Grant 2012 Latinos are predisposed). Age (Elder population). Lifestyle (obesity attributed to a sedentary lifestyle). Family history (Genetics).

10. Source: data360.org

11. Females (Schultz et al 2006). Age ( 65 and over) Lifestyles (Obesity and sedentary lifestyle) Lower socioeconomic status.

12. Pills (i.e. Glipizide, metformin, gliburide etc.) Diet and exercise Insulin shots (i.e. Humolog, Lantus, Novolog etc.) Insulin pump ( direct insulin insertion to body)

13. Source: 2007-2009 National Health Interview Survey

14. American Diabetes Association (2010). Definition and description of diabetes mellitus. Diabetes Care, 33(1), 62-69. doi: 10.2337/dc10-S062 American Diabetes Association. (2014, February 28). Symptoms. http://www.diabetes.org/diabetes-basics/symptoms/? loc=db-slabnav http://www.diabetes.org/diabetes-basics/symptoms/

15. Boyle, J. P., Thompson, T. J., Gregg, E. W., Barker, L. E., & Williamson, D. F. (2010). Projection of the year 2050 burden of diabetes in the us population: Dynamic modeling of incidence, mortality, and diabetes prevalence. Population Health Metrics, 8(29), 1-12.

16. Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2011.

17. Engelgau, M., Geiss, L., Saaddine, J., Boyle, J., Benjamin, S., Gregg, E., Tierney, E., & Imperatore, G. (2004). The evolving diabetes burden in the united states. Annals of Internal Medicine, 140(11), 945- 950.

18. Feng, B., Fang-fang, J., & Hai-feng, W. (2013). The impact of hyperglycemic emergencies on the kidney and liver. Journal of Diabetes Research, 1-11. doi: 10.1155/2013/967097 Lopez, L., & Grant, R. W. (2012). Closing the gap: Eliminating health care disparities among latinos

19. with diabetes using health information technology tools and patient navigators. Journal of Diabetes Science and Technology, 6(1), 169-176. Rull, J., Aguilar-Salinas, C., Rojas, R., Rios-Torres, J., Gomez-Perez, F., & Olaiz, G. (2005).Epidemiology of type 2 diabetes in mexico. Archives of Medical

20. Research, 36(3), 188-196. Schultz, L., Bennett, P., Ravmussin, E., Kidd, J., Kidd, K., Esparza, J., & Valencia, M. (2006). Effects of traditional and western environments on prevalence of type 2 diabetes in pima indians in mexico and the us. Diabetes Care, 29(8), 1866- 1871. Shaw, J. E., Sicree, R. A., & Zimmet, P. Z. (2010). Global estimates of

21. the prevalence of diabetes for 2010 and 2030. Diabetes Research and Clinical Practice, 87(1), 4-14. Yaturu, S. (2013). Insulin therapies: Current and future trends at dawn. World Journal of Diabetes, 4(1), 1-7.